All stock lists
Vor Biopharma Inc. (NASDAQ:VOR)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
18.33+0.07 (+0.38%)
Insider Score
––Not scored
VOR Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
VOR analyst forecast
VOR analyst consensus
Hold1 ratings
Buy 0 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
VOR 12-month price target
No published price targets in the last 12 months.
Best analysts covering VOR
- HC Wainwright & Co.8%success rate · 12 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
VOR analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Wedbush | Neutral | — | — | Reiterated | 2026-08-12 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-05-18 |
| — | Wedbush | Neutral | — | — | Reiterated | 2026-05-14 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-04-15 |
| — | Wedbush | Neutral | — | — | Reiterated | 2026-03-31 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-12-19 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-11-14 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-10-29 |
| — | Baird | Outperform | — | — | Upgraded | 2025-10-15 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-08-14 |
| — | HC Wainwright & Co. | Buy | — | — | Upgraded | 2025-06-30 |
| — | Baird | Neutral | — | — | Reiterated | 2025-06-27 |
| — | Wedbush | Neutral | — | — | Reiterated | 2025-06-26 |
| — | JMP Securities | Market Perform | — | — | Downgraded | 2025-05-09 |
| — | HC Wainwright & Co. | Neutral | — | — | Downgraded | 2025-05-09 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-03-21 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2025-03-21 |
| — | Stifel | Buy | — | — | Reiterated | 2025-03-21 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-12-10 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2024-12-10 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-11-08 |
| — | Baird | Outperform | — | — | Reiterated | 2024-11-08 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2024-09-06 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-09-06 |
| — | Barclays | Overweight | — | — | Reiterated | 2024-08-14 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2024-05-13 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2024-05-13 |
| — | Wedbush | Outperform | — | — | Reiterated | 2024-05-10 |
| — | Wedbush | Outperform | — | — | Reiterated | 2024-04-23 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2024-03-22 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2024-03-21 |
| — | Wedbush | Outperform | — | — | Reiterated | 2024-03-21 |
| — | Stifel | Buy | — | — | Reiterated | 2024-03-21 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-03-21 |
| — | Wedbush | Outperform | — | — | Reiterated | 2024-01-18 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2023-08-14 |
| — | Wedbush | Outperform | — | — | Reiterated | 2023-08-11 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-08-11 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-06-12 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-05-16 |
| — | JonesTrading | Buy | — | — | Reiterated | 2023-05-16 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2023-05-15 |
| — | Wedbush | Outperform | — | — | Reiterated | 2023-05-12 |
| — | JMP Securities | Outperform | — | — | Reiterated | 2023-03-24 |
| — | Baird | Outperform | — | — | Reiterated | 2023-03-24 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2023-03-24 |
| — | Truist Securities | Buy | — | — | Reiterated | 2023-03-24 |
| — | Stifel | Buy | — | — | Reiterated | 2023-03-24 |
| — | JMP Securities | Outperform | — | — | Reiterated | 2023-02-13 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2023-01-19 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2022-11-14 |
| — | Barclays | Overweight | — | — | Reiterated | 2022-11-11 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2022-08-15 |
| — | Wedbush | Outperform | — | — | Reiterated | 2022-07-26 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2022-05-24 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2022-05-13 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2022-04-27 |
| — | Barclays | Overweight | — | — | Reiterated | 2022-03-21 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2022-03-16 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2021-12-17 |
VOR earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-30 | -1.14 | 44.50 | $0 | $0 |
| 2026-05-13 | -0.75 | -0.73 | $0 | $0 |
| 2026-08-11 | -0.69 | -1.16 | $0 | $0 |
| 2026-11-12 | -0.82 | 0.00 | $0 | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.